Light Chain Bioscience Successfully Completes Factor VIII Mimetic Bispecific Antibody Discovery for Takeda

GENEVA, Switzerland, Feb. 14 (Korea Bizwire) — Light Chain Bioscience, a company developing bispecific antibodies with a pipeline focused in immuno-oncology, announced that it has achieved a milestone and received a payment under its research and collaboration agreement with Takeda Pharmaceutical Company Limited (Takeda). The milestone was achieved upon the successful completion of the discovery [...]